ImmuPharma (IMM.L) Stocks Surge 3.9% – Market Cap £35.4 M, 52‑Week High £14.00
Immupharma (IMM.L) sees a 3.9% jump, trading at GBX 4.10 with strong 24‑hour momentum and a 4.99% YTD rise—investors eye its biotech focus on lupus and cancer treatments.
- IMMUPHARMA PLC
- United Kingdom
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
One minute to read